Emerging Diseases News

An estimated 1 billion people worldwide develop a fungal infection each year. Of these, approximately 1.6 million will die because of their infection, a toll surpassing diseases such as malaria and tuberculosis.

This fall, older adults in the United States will have the opportunity to receive three vaccines to against fall and winter season respiratory illnesses — COVID-19, influenza and respiratory syncytial virus. 

Nearly one in five U.S. cases of leprosy is reported in Florida, with roughly 81% of cases in the state reported in central Florida, according to a study.

One in six toddlers in the United States did not complete the vaccination series for seven recommended childhood vaccines in 2019, the year before the COVID-19 pandemic, according to a study published in Pediatrics.

The American College of Chest Physicians recently issued new clinical guidance on antithrombotic therapy for arterial thrombosis and thromboembolism in patients with COVID-19.

Infectious diseases physician Jeanne M. Marrazzo, MD, MPH, will be the next director of the National Institute of Allergy and Infectious Diseases, the NIH announced Wednesday.

Strategies seeking to increase COVID-19 vaccine and booster uptake in Black patients with rheumatic diseases should consider and offer responses for racial, ethnic and socioeconomic factors, according to researchers.

Croup symptoms improved when children were exposed to 30 minutes of outdoor cold air in addition to receiving a steroid, according to the results of a randomized controlled trial published in Pediatrics.

The NIH announced that it has launched phase 2 clinical trials that will evaluate potential treatments for long COVID conditions as part of its Researching COVID to Enhance Recovery, or RECOVER, initiative.

A large study in the United Kingdom revealed some “epidemiologic nuances” of COVID-19 in children, experts said.